相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer
Archis Bagati et al.
CANCER CELL (2021)
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study
Sara M. Tolaney et al.
CLINICAL CANCER RESEARCH (2021)
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
James Isaacs et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)
The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy
Reza Bayat Mokhtari et al.
CANCERS (2021)
Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer
Yann Kieffer et al.
CANCER DISCOVERY (2020)
Role of Immunotherapy in Triple-Negative Breast Cancer
Tanya E. Keenan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Immune Escape during Breast Tumor Progression
Carlos R. Gil Del Alcazar et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent
Marie Colombe Agahozo et al.
MODERN PATHOLOGY (2020)
The ADAMTS/Fibrillin Connection: Insights into the Biological Functions of ADAMTS10 and ADAMTS17 and Their Respective Sister Proteases
Stylianos Z. Karoulias et al.
BIOMOLECULES (2020)
Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial
Sara M. Tolaney et al.
JAMA ONCOLOGY (2020)
Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
Milim Kim et al.
BREAST CANCER RESEARCH (2020)
Mouse ER+/PIK3CAH1047R breast cancers caused by exogenous estrogen are heterogeneously dependent on estrogen and undergo BIM-dependent apoptosis with BH3 and PI3K agents
Elias E. Stratikopoulos et al.
ONCOGENE (2019)
Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy
Vikash P. Chauhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Margaret L. Axelrod et al.
CLINICAL CANCER RESEARCH (2019)
Context-dependent roles of complement in cancer
Lubka T. Roumenina et al.
NATURE REVIEWS CANCER (2019)
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
Yan Lan et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface
Apoorvi Chaudhri et al.
CANCER IMMUNOLOGY RESEARCH (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy
Dominik Schmiedel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS)
Rinaa S. Punglia et al.
JNCI CANCER SPECTRUM (2018)
CD74 and intratumoral immune response in breast cancer
Zhi-Qiang Wang et al.
ONCOTARGET (2017)
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
Carlos R. Gil Del Alcazar et al.
CANCER DISCOVERY (2017)
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Takahiro Tsujikawa et al.
CELL REPORTS (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
David A. Reardon et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants
Ruibin Xi et al.
NUCLEIC ACIDS RESEARCH (2016)
Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression
Yu Wang et al.
CANCER DISCOVERY (2016)
Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling
Hee Jin Lee et al.
ONCOTARGET (2016)
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors
Sabrina Rossi et al.
ONCOTARGET (2016)
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Eduardo Bonavita et al.
CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
IMGT®, the international ImMunoGeneTics information system® 25 years on
Marie-Paule Lefranc et al.
NUCLEIC ACIDS RESEARCH (2015)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Szeman Ruby Chan et al.
BREAST CANCER RESEARCH (2012)
Adenomyoepithelioma of the breast: a review stressing its propensity for malignant transformation
Malcolm M. Hayes
JOURNAL OF CLINICAL PATHOLOGY (2011)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema
DG Morris et al.
NATURE (2003)
Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production
JA Brown et al.
JOURNAL OF IMMUNOLOGY (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Atlas and histologic classification of tumors of the rat mammary gland
J Russo et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2000)
分享论文
